Tacrolimus is highly effective in both dual and triple therapy regimens following renal transplantation

Transplant International

Volumn 13, Issue SUPPL. 1, 2000, Pages

  Segoloni, G ^a   Bonomini, V ^b   Maresca, M C ^c   Arisi, L ^d   Gonzalez Molina, M ^e   Tarantino, A ^f   Del Castillo, D ^g   Ortuno J ^h   Carmellini, M ⁱ   Capdevila, L ^j   Arias, M ^k   Garcia, J ^l   Rigotti, P ^m  

^a MOLINETTE HOSPITAL   (Italy)

^b UNIVERSITY OF BOLOGNA   (Italy)

^c OSPEDALE CA FONCELLO   (Italy)

^d UNIVERSITY HOSPITAL OF PARMA   (Italy)

^e HOSPITAL REGIONAL UNIVERSITARIO DE MÁLAGA   (Spain)

^f FONDAZIONE IRCCS CA GRANDA OSPEDALE MAGGIORE POLICLINICO   (Italy)

^g HOSPITAL UNIVERSITARIO REINA SOFÍA   (Spain)

^h HOSPITAL RAMÓN Y CAJAL   (Spain)

ⁱ Azienda Ospedaliera S Chiara Presidio di Cisanello   (Italy)

^j HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^k HOSPITAL UNIVERSITARIO MARQUÉS DE VALDECILLA   (Spain)

^l HOSPITAL UNIVERSITARIO LA FE   (Spain)

^m UNIVERSITY OF PADOVA   (Italy)

more..

Author keywords

Azathioprine; Dual vs triple therapy; Kidney transplantation; Rejection; Tacrolimus

Indexed keywords

IMMUNOSUPPRESSIVE AGENT; TACROLIMUS;

ACUTE DISEASE; ADULT; AGED; ARTICLE; BLOOD; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG COMBINATION; FEMALE; GRAFT REJECTION; GRAFT SURVIVAL; HUMAN; IMMUNOLOGY; INCIDENCE; ITALY; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; MORTALITY; MULTICENTER STUDY; PATIENT SELECTION; PHASE 3 CLINICAL TRIAL; PHYSIOLOGY; RANDOMIZED CONTROLLED TRIAL; REOPERATION; SPAIN; SURVIVAL RATE; TIME;

ACUTE DISEASE; ADULT; AGED; DRUG THERAPY, COMBINATION; FEMALE; GRAFT REJECTION; GRAFT SURVIVAL; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INCIDENCE; ITALY; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; PATIENT SELECTION; REOPERATION; SPAIN; SURVIVAL RATE; TACROLIMUS; TIME FACTORS;

EID: 18044367989     PISSN: 09340874     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1432-2277.2000.tb02054.x     Document Type: Article

References (7)

1. Bergan S (1998) Azathioprine monitoring in renal transplantation, University of Oslo, Rikshospitalet. ISBN 82-7633-106-8
2. Claesson K, Mayer AD, Squifflet JP, et al (1998) Lipoprotein patterns in renal transplant patients: a comparison between FK 506 and cyclosporine A patients. Transplant Proc 30: 1292-1294
3. Mayer AD, Dmitrewski J, Squifflet JP, et al (1997) Multicenter randomized trial comparing tacrolimus (FK506) and cyclosporine in the prevention of renal allograft rejection. Transplantation 64: 436-443
4. Pirsch JD, Miller J, Deierhoi MH, et al (1997) A comparison of tacrolimus (FK506) and cyclosporine for immunosuppression after cadaveric renal transplantation. Transplantation 63: 977-983
5. Shapiro R, Jordan ML, Scantlebury VP, et al (1995) A prospective randomized trial of FK506-based immunosuppression after renal transplantation. Transplantation 59: 485-490
6. Shapiro R, Jordan ML, Scantlebury VP, et al (1995) A prospective, randomized trial of FK506/prednisone vs FK506/azathioprine/prednisone in renal transplant patients. Transplant Proc 27: 814-817
7. Walker RG (1994) Nonspecific immunosuppression: azathioprine and steroids. In: Morgan JP (ed) Kidney transplantation. Principles and practice, 4th edn. Saunders, pp 202-214